Ad-hoc | 21 August 2025 17:45
MeVis Medical Solutions AG: Forecast adjustment for the 2024/2025 fiscal year
|
MeVis Medical Solutions AG / Key word(s): Change in Forecast
Bremen, August 21, 2025 – MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, is adjusting its forecast for the current fiscal year based on preliminary figures for the first ten months. For fiscal year 2024/2025 (October 1, 2024 to September 30, 2025), revenue is now expected to decline slightly to between €16.5 million and €17.0 million (previous forecast: €17.0 million to €17.5 million). MeVis expects EBIT (earnings before interest and taxes) to decline to between €3.0 million and €3.5 million (previous forecast: €3.5 million to €4.0 million). License sales are below expectations and cannot be offset by maintenance revenues and other revenues. ************************************************************************ Contact: Kirchhoff, Marcus / CEO End of Inside Information
21-Aug-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|
| Language: | English |
| Company: | MeVis Medical Solutions AG |
| Caroline-Herschel-Str. 1 | |
| 28359 Bremen | |
| Germany | |
| Phone: | +49 421 224 95 0 |
| Fax: | +49 421 224 95 999 |
| E-mail: | ir@mevis.de |
| Internet: | http://www.mevis.de |
| ISIN: | DE000A0LBFE4 |
| WKN: | A0LBFE |
| Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2187294 |
| End of Announcement | EQS News Service |
|
|
2187294 21-Aug-2025 CET/CEST